The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Incyte
Consulting or Advisory Role - Bayer; Merck
Travel, Accommodations, Expenses - Mundipharma; Mylan; SERVIER
Regorafenib (REG) combined with irinotecan (IRI) versus IRI alone as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas (mGA): A randomized phase II trial (PRODIGE 58 – UCGI 35 – REGIRI).
 
Emmanuelle Samalin
Honoraria - BMS (Inst)
Consulting or Advisory Role - Astellas Pharma; DAICHI; MSD Oncology (Inst); Pierre Fabre; SERVIER
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre; SERVIER
 
Hélène Senellart
No Relationships to Disclose
 
Ludovic Evesque
Honoraria - AstraZeneca; SERVIER
 
Olivier Bouché
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; Pierre Fabre; Sanofi; Servier
 
Faiza Khemissa
Honoraria - Roche; Roche; SERVIER
Travel, Accommodations, Expenses - Ipsen; Roche; Roche; Sanofi; SERVIER
 
Christelle De La Fouchardiere
Honoraria - Merck Serono; Merck Serono; Roche; Roche
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Ipsen; Lilly; MSD Oncology; Pierre Fabre; Roche; SERVIER
Research Funding - Pierre Fabre (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Pierre Fabre; Roche; SERVIER; SERVIER
Other Relationship - Amgen; Incyte; MSD Oncology
 
Anthony Lopez
Honoraria - Amgen
Consulting or Advisory Role - Bayer; Ipsen; Merck; Pierre Fabre; Sanofi; SERVIER; Viatris; Vifor Pharma
Research Funding - Roche
Travel, Accommodations, Expenses - Abbvie; Amgen; Bayer; Ipsen; MSD; Mundipharma; Novartis; Vifor Pharma
 
Slimane Dermeche
No Relationships to Disclose
 
Damien Botsen
Honoraria - Amgen; Merck; Pierre Fabre; SERVIER
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Bayer
 
David Tougeron
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AstraZeneca; MSD; Novartis; Pierre Fabre; Sanofi
Research Funding - AstraZeneca (Inst); BTG (Inst); MSD (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Sanofi
 
Aziz Zaanan
Honoraria - Amgen; Baxter; Lilly; Merck Serono; MSD; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Baxter; Lilly; Merck Serono; MSD; Roche; Sanofi; SERVIER
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; SERVIER
 
Meher BEN Abdelghani
No Relationships to Disclose
 
Emmanuel Guardiola
No Relationships to Disclose
 
Olivier Dubreuil
Consulting or Advisory Role - Merck Serono; MSD Oncology; Sanofi; SERVIER; SERVIER
Travel, Accommodations, Expenses - Amgen; Amgen; Ipsen; Merck Serono; MSD Oncology; Novartis; Sanofi; SERVIER
 
Valérie Le Brun Ly
Consulting or Advisory Role - Ipsen
 
Audrey Hennequin
No Relationships to Disclose
 
Nicolas De Sousa Carvalho
No Relationships to Disclose
 
Florence Castan
No Relationships to Disclose
 
Anthony Turpin
Honoraria - Mylan; SERVIER